Five year follow-up study of sixty cases of inflammatory diseases treated with alternate day corticosteroid therapy.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy*; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003095:Collagen Diseases / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy; D010493:Pericarditis / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012189:Retrospective Studies; D013997:Time Factors; D014581:Urticaria / Q000188:drug therapy
D007136:Immunoglobulins; D011241:Prednisone